A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10)	B-cell chronic lymphocytic leukemia, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic lymphocytic leukemia/small lymphocytic lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 2	2026-06-22		NCT07154264

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Dizal Pharmaceuticals	20

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hospital of Nantong University	Nantong	China	33
Anhui Provincial Cancer Hospital	Hefei	China	22
Henan Cancer Hospital	Zhengzhou	China	67
Hunan Cancer Hospital	Changsha	China	123
Nanfang Hospital, Southern Medical University	Guangzhou	China	83
Peking University Third Hospital	Beijing	China	123
Shengjing Hospital Of China Medical University	Shenyang	China	54
The First Affiliated Hospital of Nanchang University	Nanchang	China	109
The first Affiliated Hospital, Zhejiang University School of Medicine	Hangzhou	China	69
The First Bethune Hospital of Jilin University	Changchun	China	13
The First People's Hospital of Changzhou	Changzhou	China	9
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	77
West China Hospital of Sichuan University	Chengdu	China	117
Yichang Central People's Hospital	Yichang	China	17
Zhujiang Hospital of Southern Medical University	Guangzhou	China	33